Mireya Robledo-Aceves, América A Corona-Gutiérrez, Eva E Camarena-Pulido, Alejandro Barrón-Balderas, Carlos Meza-López, Ruth Y Ramos-Gutiérrez, Jesús Gutiérrez-Rojas
Introduction: The increase in the production of substances to enhance the quality of life, the biodiversity of the different ecosystems in Mexico, and the unique characteristics of pediatric patients, contribute to intoxications within this population.
Method: Analytical retrospective study of admissions to pediatric emergency care due to poisoning in < 16-year-old (2016 to 2020). Included variables were age, gender, type of toxic substance, exposure characteristics, and the season of the year. Frequencies, percentages, range, average and standard deviation were obteined. In the bivariate análisis, the Chi square test was used. A p-value < 0.05 was considered statistically significant.
Results: Over 5 years, there were 459 cases, with a prevalence of 3.16%. No gender predominance was observed. The most common was caused by venomous animals (28.5%), followed by medication ingestion (27.6%). Only 5% of cases were suicide attempts, the rest were accidental (95%). Children up to 5 years old were more commonly by medication ingestion, hydrocarbons, or household products (p = 0.03, p = 0.0001), while the causes in older children were contact with venomous animals and ingestion of stimulants drugs (alcohol, amphetamines, cannabis, cocaine) (p = 0.0001, p = 0.006). Intoxication with quaternary ammonium herbicides was lethal in all cases.
Conclusions: Children under the age of 5 are more susceptible to intoxication from common household products. Older kids tend to be more frequently a combination of stimulants drugs.
{"title":"Epidemiology of acute childhood poisoning in pediatric emergencies in Western Mexico.","authors":"Mireya Robledo-Aceves, América A Corona-Gutiérrez, Eva E Camarena-Pulido, Alejandro Barrón-Balderas, Carlos Meza-López, Ruth Y Ramos-Gutiérrez, Jesús Gutiérrez-Rojas","doi":"10.24875/BMHIM.23000183","DOIUrl":"10.24875/BMHIM.23000183","url":null,"abstract":"<p><strong>Introduction: </strong>The increase in the production of substances to enhance the quality of life, the biodiversity of the different ecosystems in Mexico, and the unique characteristics of pediatric patients, contribute to intoxications within this population.</p><p><strong>Method: </strong>Analytical retrospective study of admissions to pediatric emergency care due to poisoning in < 16-year-old (2016 to 2020). Included variables were age, gender, type of toxic substance, exposure characteristics, and the season of the year. Frequencies, percentages, range, average and standard deviation were obteined. In the bivariate análisis, the Chi square test was used. A p-value < 0.05 was considered statistically significant.</p><p><strong>Results: </strong>Over 5 years, there were 459 cases, with a prevalence of 3.16%. No gender predominance was observed. The most common was caused by venomous animals (28.5%), followed by medication ingestion (27.6%). Only 5% of cases were suicide attempts, the rest were accidental (95%). Children up to 5 years old were more commonly by medication ingestion, hydrocarbons, or household products (p = 0.03, p = 0.0001), while the causes in older children were contact with venomous animals and ingestion of stimulants drugs (alcohol, amphetamines, cannabis, cocaine) (p = 0.0001, p = 0.006). Intoxication with quaternary ammonium herbicides was lethal in all cases.</p><p><strong>Conclusions: </strong>Children under the age of 5 are more susceptible to intoxication from common household products. Older kids tend to be more frequently a combination of stimulants drugs.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 5","pages":"287-293"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ricardo Rodriguez-Portilla, Herminio R Hernández-Díaz
Introduction: Septic shock is a potentially life-threatening condition. The aim of this study was to identify clinical and epidemiological factors associated with mortality in pediatric patients admitted to a pediatric intensive care unit (PICU) with septic shock.
Materials and methods: A retrospective comparative case series study was conducted with children aged 1 month to 14 years with septic shock from 2018 to 2020 in a PICU in Lima, Peru. Patients were divided into deceased and survivor groups based on their condition at discharge from the PICU. The influence of each variable on mortality was assessed using a logistic regression model.
Results: A total of 174 patients were included in the study, with 51 (29.3%) fatalities. Deceased patients, compared to survivors, were older, had a higher incidence of oncological disease (31.4% vs. 14.6%; p = 0.011), more frequently presented with hemoglobin ≤ 9 g/dL (44% vs. 28%; p = 0.043), lactate > 2 mmol/L (70% vs. 44%; p = 0.002), platelets ≤ 150 (×103)/μL (77% vs. 42%; p < 0.001), and pH ≤ 7.1 (31% vs. 6%; p < 0.001). In the logistic regression model, factors related to mortality were having a pH ≤ 7.1 (odds ratio [OR] = 8.95; 95% confidence interval [CI]: 2.52-31.75) and platelets ≤ 150 (×103)/μL (OR = 3.89; 95% CI: 1.40-10.84).
Conclusions: Factors associated with mortality in pediatric patients with septic shock were a pH ≤ 7.1 and platelets ≤ 150 (×103)/μL in the assessments conducted upon admission to the PICU.
简介脓毒性休克是一种可能危及生命的疾病。本研究旨在确定与儿科重症监护室(PICU)收治的脓毒性休克儿科患者死亡率相关的临床和流行病学因素:本研究对秘鲁利马一家儿科重症监护室 2018 年至 2020 年期间收治的 1 个月至 14 岁脓毒性休克患儿进行了回顾性病例系列比较研究。根据患者从 PICU 出院时的情况将其分为死亡组和存活组。采用逻辑回归模型评估了各变量对死亡率的影响:共有 174 名患者参与研究,其中 51 人(29.3%)死亡。与存活者相比,死亡患者年龄更大,肿瘤疾病发生率更高(31.4% vs. 14.6%; p = 0.011),血红蛋白≤9 g/dL 的比例更高(44% vs. 28%; p = 0.041)。28%; p = 0.043)、乳酸大于 2 mmol/L (70% vs. 44%; p = 0.002)、血小板小于 150 (×103)/μL (77% vs. 42%; p < 0.001)、pH 值小于 7.1 (31% vs. 6%; p < 0.001)。在逻辑回归模型中,pH值≤7.1(几率比[OR]=8.95;95% 置信区间[CI]:2.52-31.75)和血小板≤150(×103)/μL(OR=3.89;95% CI:1.40-10.84)是与死亡率相关的因素:结论:脓毒性休克儿科患者入院时进行的评估显示,pH值≤7.1和血小板≤150 (×103)/μL 是导致其死亡的相关因素。
{"title":"Clinical and epidemiological factors related to mortality due to septic shock in a pediatric intensive care unit.","authors":"Ricardo Rodriguez-Portilla, Herminio R Hernández-Díaz","doi":"10.24875/BMHIM.24000023","DOIUrl":"https://doi.org/10.24875/BMHIM.24000023","url":null,"abstract":"<p><strong>Introduction: </strong>Septic shock is a potentially life-threatening condition. The aim of this study was to identify clinical and epidemiological factors associated with mortality in pediatric patients admitted to a pediatric intensive care unit (PICU) with septic shock.</p><p><strong>Materials and methods: </strong>A retrospective comparative case series study was conducted with children aged 1 month to 14 years with septic shock from 2018 to 2020 in a PICU in Lima, Peru. Patients were divided into deceased and survivor groups based on their condition at discharge from the PICU. The influence of each variable on mortality was assessed using a logistic regression model.</p><p><strong>Results: </strong>A total of 174 patients were included in the study, with 51 (29.3%) fatalities. Deceased patients, compared to survivors, were older, had a higher incidence of oncological disease (31.4% vs. 14.6%; p = 0.011), more frequently presented with hemoglobin ≤ 9 g/dL (44% vs. 28%; p = 0.043), lactate > 2 mmol/L (70% vs. 44%; p = 0.002), platelets ≤ 150 (×10<sup>3</sup>)/μL (77% vs. 42%; p < 0.001), and pH ≤ 7.1 (31% vs. 6%; p < 0.001). In the logistic regression model, factors related to mortality were having a pH ≤ 7.1 (odds ratio [OR] = 8.95; 95% confidence interval [CI]: 2.52-31.75) and platelets ≤ 150 (×10<sup>3</sup>)/μL (OR = 3.89; 95% CI: 1.40-10.84).</p><p><strong>Conclusions: </strong>Factors associated with mortality in pediatric patients with septic shock were a pH ≤ 7.1 and platelets ≤ 150 (×10<sup>3</sup>)/μL in the assessments conducted upon admission to the PICU.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 4","pages":"210-216"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
María F Carrillo-Vega, Juan M Mireles-Dorantes, Samara Mendienta-Zerón, Guillermo Salinas-Escudero, Filiberto Toledano Toledano, Victor Granados-García
Background: Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. The polyarticular course (polyarthritis) represents 63-66% of patients with JIA. The aim was to determine the direct medical costs (DMC) of JIA of the polyarthritis type in pediatric patients of a tertiary hospital in Mexico.
Methods: An analysis of the disease costs was developed from the perspective of the Instituto de Seguridad Social del Estado de México y Municipios Maternal and Child Hospital (HMI). The time horizon was 12 years. All patients diagnosed with JIA with polyarticular course treated by the pediatric rheumatology service of the HMI from January to September 2022 and with an active clinical record were included. Different costing techniques were used. The cost components were consultations, medications, hospitalization, and office and laboratory studies. The costs are reported in USD 2021.
Results: Twenty-six records of patients with polyarticular arthritis from the HMI were analyzed, with a mean of 4,555.2 USD (standard deviation [SD] = 1,456.7) and a median of 3,828 USD (SD = 1,492) in the first 10 years of treatment. The components of DMC were medications (82.7%), office and laboratory studies (8.4%), hospitalization (8.0%), and consultations (1.8%). Biological disease-modifying drugs (bDMARDs) accounted for 95.3% of the drug component cost.
Conclusion: The cost of bDMARDs represented the most critical cost of polyarticular JIA, reflected in the 2nd year of treatment. Including generic bDMARDs and reviewing purchase prices by health institutions in Mexico is necessary.
{"title":"Direct medical costs of polyarthritis in a pediatric hospital in Mexico.","authors":"María F Carrillo-Vega, Juan M Mireles-Dorantes, Samara Mendienta-Zerón, Guillermo Salinas-Escudero, Filiberto Toledano Toledano, Victor Granados-García","doi":"10.24875/BMHIM.24000079","DOIUrl":"https://doi.org/10.24875/BMHIM.24000079","url":null,"abstract":"<p><strong>Background: </strong>Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. The polyarticular course (polyarthritis) represents 63-66% of patients with JIA. The aim was to determine the direct medical costs (DMC) of JIA of the polyarthritis type in pediatric patients of a tertiary hospital in Mexico.</p><p><strong>Methods: </strong>An analysis of the disease costs was developed from the perspective of the Instituto de Seguridad Social del Estado de México y Municipios Maternal and Child Hospital (HMI). The time horizon was 12 years. All patients diagnosed with JIA with polyarticular course treated by the pediatric rheumatology service of the HMI from January to September 2022 and with an active clinical record were included. Different costing techniques were used. The cost components were consultations, medications, hospitalization, and office and laboratory studies. The costs are reported in USD 2021.</p><p><strong>Results: </strong>Twenty-six records of patients with polyarticular arthritis from the HMI were analyzed, with a mean of 4,555.2 USD (standard deviation [SD] = 1,456.7) and a median of 3,828 USD (SD = 1,492) in the first 10 years of treatment. The components of DMC were medications (82.7%), office and laboratory studies (8.4%), hospitalization (8.0%), and consultations (1.8%). Biological disease-modifying drugs (bDMARDs) accounted for 95.3% of the drug component cost.</p><p><strong>Conclusion: </strong>The cost of bDMARDs represented the most critical cost of polyarticular JIA, reflected in the 2<sup>nd</sup> year of treatment. Including generic bDMARDs and reviewing purchase prices by health institutions in Mexico is necessary.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 6","pages":"356-367"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142692477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alexander Casallas-Vega, David Andrade-Fonseca, Jaime J. Pérez-Niño, Jeisson A. Hincapié-Carvajal, Juan P. Castañeda-González, Samanta Del R. Herrera-Valladares, Sandra M. Hernández-Zambrano
Background: Pediatric cancer is a complex disease that requires interdisciplinary interventions. This study aims to describe the quality of life and exhaustion levels in children diagnosed with cancer, using validated instruments that reflect the peculiarities of this disease.
Method: An observational analytical study was conducted on children and adolescents aged 2 to 18 years with cancer. The PedsQL Cancer Module and FACIT-F instruments were used to assess quality of life and fatigue, respectively, with statistical analysis performed to identify correlations and develop an explanatory model.
Results: Notable physical and psychological symptoms such as nausea, fatigue, hyporexia, irritability, and sadness were identified. The PedsQL and FACIT-F indicated a diminished quality of life. There was high concordance between the perceptions of children and their parents, except in the anxiety related to procedures, where children reported higher levels. These symptoms reflect the impact of cancer treatment on children's well-being. The concordance in evaluations suggests that parents have a good understanding of these experiences, highlighting the relevance of psychosocial interventions to improve quality of life through an adequate support network.
Conclusions: It is crucial that pediatric cancer treatment addresses not only medical aspects but also the comprehensive support for the emotional and psychosocial well-being of the patients and their families.
{"title":"Quality of life and burnout: children and adolescents in cancer treatment.","authors":"Alexander Casallas-Vega, David Andrade-Fonseca, Jaime J. Pérez-Niño, Jeisson A. Hincapié-Carvajal, Juan P. Castañeda-González, Samanta Del R. Herrera-Valladares, Sandra M. Hernández-Zambrano","doi":"10.24875/BMHIM.24000063","DOIUrl":"10.24875/BMHIM.24000063","url":null,"abstract":"<p><strong>Background: </strong>Pediatric cancer is a complex disease that requires interdisciplinary interventions. This study aims to describe the quality of life and exhaustion levels in children diagnosed with cancer, using validated instruments that reflect the peculiarities of this disease.</p><p><strong>Method: </strong>An observational analytical study was conducted on children and adolescents aged 2 to 18 years with cancer. The PedsQL Cancer Module and FACIT-F instruments were used to assess quality of life and fatigue, respectively, with statistical analysis performed to identify correlations and develop an explanatory model.</p><p><strong>Results: </strong>Notable physical and psychological symptoms such as nausea, fatigue, hyporexia, irritability, and sadness were identified. The PedsQL and FACIT-F indicated a diminished quality of life. There was high concordance between the perceptions of children and their parents, except in the anxiety related to procedures, where children reported higher levels. These symptoms reflect the impact of cancer treatment on children's well-being. The concordance in evaluations suggests that parents have a good understanding of these experiences, highlighting the relevance of psychosocial interventions to improve quality of life through an adequate support network.</p><p><strong>Conclusions: </strong>It is crucial that pediatric cancer treatment addresses not only medical aspects but also the comprehensive support for the emotional and psychosocial well-being of the patients and their families.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 6","pages":"337-345"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142692636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Andrea Ríos-Sánchez, Juan A Godínez-Chaparro, Marissa de J Quintal-Ramírez, Ixchel R Ramírez-Ricarte
Introduction: Linear IgA bullous dermatosis (LABD) is a rare autoimmune disease. Although dapsone is the initial treatment, other immunomodulators are used in resistant cases or when dapsone is unavailable.
Case report: A 12-year-old Mexican child, with no relevant medical history, developed in May 2023 a disseminated dermatosis affecting all body segments, including mucous membranes, characterized by erythematous patches and plaques evolving into the formation of serous and serosanguinous blisters and vesicles, distributed in a "string of pearls" pattern. LABD was suspected and confirmed by skin biopsy, which showed a subepidermal blister with neutrophilic infiltration and linear Immunoglobulin A deposits at the dermo-epidermal junction by direct immunofluorescence. Treatment with prednisone (2 mg/kg/day) and cyclosporine (5 mg/kg/day) resulted in improvement and lesion remission within 2 weeks. Both drugs needed to be discontinued for 3 months due to intermittent blistering. Cyclosporine was continued as maintenance therapy at a dose of 4 mg/kg/day for 8 months.
Conclusions: The report highlights the use of cyclosporine as an alternative immunomodulator for DAAL, an immunosuppressive agent used in autoimmune disorders. Few cases, including this one, have described complete remission and control of the dermatosis with cyclosporine, accompanied by prednisone at the start of treatment.
简介线性 IgA 大疱性皮肤病(LABD)是一种罕见的自身免疫性疾病。虽然多泼松是最初的治疗方法,但在耐药病例或无法使用多泼松时,也会使用其他免疫调节剂:病例报告:一名 12 岁的墨西哥儿童,无相关病史,于 2023 年 5 月患上播散性皮炎,累及全身各处,包括粘膜,以红斑和斑块演变为浆液性和浆液性水疱和囊泡为特征,呈 "珍珠串 "状分布。直接免疫荧光显示表皮下水疱有中性粒细胞浸润,真皮表皮交界处有线状免疫球蛋白 A 沉积。使用泼尼松(2 毫克/千克/天)和环孢素(5 毫克/千克/天)治疗后,病情得到改善,皮损在两周内缓解。由于出现间歇性水疱,两种药物均需停用 3 个月。环孢素的维持治疗剂量为4毫克/千克/天,持续了8个月:本报告强调了环孢素作为 DAAL 的替代免疫调节剂的用途,DAAL 是一种用于自身免疫性疾病的免疫抑制剂。包括本病例在内,很少有病例描述使用环孢素后皮肤病得到完全缓解和控制,治疗开始时还伴有泼尼松。
{"title":"Linear IgA bullous dermatosis in a latin adolescent treated with cyclosporine and prednisone.","authors":"Andrea Ríos-Sánchez, Juan A Godínez-Chaparro, Marissa de J Quintal-Ramírez, Ixchel R Ramírez-Ricarte","doi":"10.24875/BMHIM.24000043","DOIUrl":"10.24875/BMHIM.24000043","url":null,"abstract":"<p><strong>Introduction: </strong>Linear IgA bullous dermatosis (LABD) is a rare autoimmune disease. Although dapsone is the initial treatment, other immunomodulators are used in resistant cases or when dapsone is unavailable.</p><p><strong>Case report: </strong>A 12-year-old Mexican child, with no relevant medical history, developed in May 2023 a disseminated dermatosis affecting all body segments, including mucous membranes, characterized by erythematous patches and plaques evolving into the formation of serous and serosanguinous blisters and vesicles, distributed in a \"string of pearls\" pattern. LABD was suspected and confirmed by skin biopsy, which showed a subepidermal blister with neutrophilic infiltration and linear Immunoglobulin A deposits at the dermo-epidermal junction by direct immunofluorescence. Treatment with prednisone (2 mg/kg/day) and cyclosporine (5 mg/kg/day) resulted in improvement and lesion remission within 2 weeks. Both drugs needed to be discontinued for 3 months due to intermittent blistering. Cyclosporine was continued as maintenance therapy at a dose of 4 mg/kg/day for 8 months.</p><p><strong>Conclusions: </strong>The report highlights the use of cyclosporine as an alternative immunomodulator for DAAL, an immunosuppressive agent used in autoimmune disorders. Few cases, including this one, have described complete remission and control of the dermatosis with cyclosporine, accompanied by prednisone at the start of treatment.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 5","pages":"305-310"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elsa M Zúñiga-Lara, César M Zambrano-Virgen, José F Gaytán-Morales, Fredenet O Mendoza-Camargo, Yazmin A Gómez-Domínguez
Background: We present the case of a patient who underwent hematopoietic progenitor cell transplantation from a fully compatible unrelated donor and subsequently developed Grade IV skin graft-versus-host disease (GVHD) resembling toxic epidermal necrolysis (TEN).
Clinical case: An 11-year-old female, post-transplantation of hematopoietic progenitor cells from a 100% compatible unrelated donor, developed rash-like skin lesions on the trunk and extremities on day +35. A skin biopsy revealed dermal atrophy, vacuolization of the basal layer, and confluent apoptotic keratinocytes with mononuclear inflammatory cells in the dermoepidermis, confirming the diagnosis of TENlike acute cutaneous GVHD.
Conclusion: The patient experienced an 80% remission of symptoms following dynamic management of immunosuppressants.
背景:临床病例:一名 11 岁女性患者接受了完全相合的非亲缘供体的造血祖细胞移植,随后出现了类似中毒性表皮坏死(TEN)的 IV 级皮肤移植物抗宿主病(GVHD):临床病例:一名 11 岁女性在移植了来自 100%相合的非亲缘供体的造血祖细胞后,于第 +35 天在躯干和四肢出现皮疹样皮损。皮肤活检显示真皮萎缩、基底层空泡化、真皮表皮层有单核炎症细胞汇集的凋亡角质细胞,确诊为 TEN 样急性皮肤 GVHD:结论:在使用免疫抑制剂进行动态治疗后,患者的症状缓解了80%。
{"title":"Graft-versus-host disease variety toxic epidermal necrolysis. Case report.","authors":"Elsa M Zúñiga-Lara, César M Zambrano-Virgen, José F Gaytán-Morales, Fredenet O Mendoza-Camargo, Yazmin A Gómez-Domínguez","doi":"10.24875/BMHIM.24000048","DOIUrl":"https://doi.org/10.24875/BMHIM.24000048","url":null,"abstract":"<p><strong>Background: </strong>We present the case of a patient who underwent hematopoietic progenitor cell transplantation from a fully compatible unrelated donor and subsequently developed Grade IV skin graft-versus-host disease (GVHD) resembling toxic epidermal necrolysis (TEN).</p><p><strong>Clinical case: </strong>An 11-year-old female, post-transplantation of hematopoietic progenitor cells from a 100% compatible unrelated donor, developed rash-like skin lesions on the trunk and extremities on day +35. A skin biopsy revealed dermal atrophy, vacuolization of the basal layer, and confluent apoptotic keratinocytes with mononuclear inflammatory cells in the dermoepidermis, confirming the diagnosis of TENlike acute cutaneous GVHD.</p><p><strong>Conclusion: </strong>The patient experienced an 80% remission of symptoms following dynamic management of immunosuppressants.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 6","pages":"368-371"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142692478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Drugs and natural products for the treatment of COVID-19 during 2020: comment.","authors":"Hineptch Daungsupawong, Viroj Wiwanitkit","doi":"10.24875/BMHIM.24000042","DOIUrl":"10.24875/BMHIM.24000042","url":null,"abstract":"","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 4","pages":"255"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Juan A Godínez-Chaparro, Helena Vidaurri-de la Cruz, Karen Oyorzabal-Serrano, Ixchel R Ramírez-Ricarte
Background: Pilomatricoma is a common benign adnexal neoplasm in children. There are few epidemiological studies on this subject, with most relying solely on descriptive statistics.
Methods: A cross-sectional study conducted in two tertiary hospitals in Mexico City from January 2017 to December 2023. Clinical and electronic records of patients with histopathological diagnosis of pilomatricoma, both sexes, under 18 years old, with any type of present comorbidity were selected. Records of patients with diagnosis not confirmed by histopathology or incomplete records were not included in the study.
Results: Fifty-two cases with pilomatrixoma were included in the study, showing a total of 74 lesions. About 23.1% of the cases had multiple pilomatrixomas. 40.4% of the cases experienced pain; this symptom was associated with lesions > 15 mm in diameter and with multiple pilomatrixomas. Risk factors for lesions > 15 mm included age under 8 years, positive tent sign, tumor evolution longer than a year, and a non-classical clinical variety. The head and neck were the most commonly affected areas. The left upper extremity presented larger pilomatrixomas (median 18.5 mm) and occurred more frequently in adolescent patients (mean age 12.1 years) compared to other body areas.
Conclusions: Pilomatrixoma in children shows clinical diversity, with specific findings based on size, number, and anatomical location.
{"title":"Clinical and epidemiological characteristics of pilomatricomas in a Mexican pediatric population.","authors":"Juan A Godínez-Chaparro, Helena Vidaurri-de la Cruz, Karen Oyorzabal-Serrano, Ixchel R Ramírez-Ricarte","doi":"10.24875/BMHIM.24000067","DOIUrl":"10.24875/BMHIM.24000067","url":null,"abstract":"<p><strong>Background: </strong>Pilomatricoma is a common benign adnexal neoplasm in children. There are few epidemiological studies on this subject, with most relying solely on descriptive statistics.</p><p><strong>Methods: </strong>A cross-sectional study conducted in two tertiary hospitals in Mexico City from January 2017 to December 2023. Clinical and electronic records of patients with histopathological diagnosis of pilomatricoma, both sexes, under 18 years old, with any type of present comorbidity were selected. Records of patients with diagnosis not confirmed by histopathology or incomplete records were not included in the study.</p><p><strong>Results: </strong>Fifty-two cases with pilomatrixoma were included in the study, showing a total of 74 lesions. About 23.1% of the cases had multiple pilomatrixomas. 40.4% of the cases experienced pain; this symptom was associated with lesions > 15 mm in diameter and with multiple pilomatrixomas. Risk factors for lesions > 15 mm included age under 8 years, positive tent sign, tumor evolution longer than a year, and a non-classical clinical variety. The head and neck were the most commonly affected areas. The left upper extremity presented larger pilomatrixomas (median 18.5 mm) and occurred more frequently in adolescent patients (mean age 12.1 years) compared to other body areas.</p><p><strong>Conclusions: </strong>Pilomatrixoma in children shows clinical diversity, with specific findings based on size, number, and anatomical location.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 5","pages":"263-271"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
José F Mier-de Leija, Daniela de la Rosa-Zamboni, Juan J L Sienra-Monge, Horacio Márquez-González, Solange G Koretzky
Background: Hand hygiene (HH) is an important strategy for preventing health-care-associated infections (HAIs). Few programs focus on HH for family members and primary caregivers but fewer for patients. This study aimed to estimate the frequency with which hospitalized pediatric patients have hand contact with hospital surfaces.
Methods: We conducted a cross-sectional descriptive observational study consisting of three phases: the first was the creation of an observation and data collection tool, the second was the training of the monitors, and the third was the observational study of hand contact and HH opportunities in hospitalized pediatric patients.
Results: Over 3600 minutes of observation, 2032 HH opportunities were detected, averaging 33.8/h (SD 4.7) as determined by hand contact with hospital surfaces of hospitalized pediatric patients. In our study, infants and preschool children had the highest frequency of hand contact.
Conclusion: The high frequency of hand contact of hospital surfaces by children suggests that hourly hand disinfection of patients and caregivers, objects and surfaces around the patients may be prevention measures that could be incorporated to reduce HAIs in pediatric hospitals.
{"title":"Frequency of hand contact with hospital surfaces in hospitalized pediatric patients.","authors":"José F Mier-de Leija, Daniela de la Rosa-Zamboni, Juan J L Sienra-Monge, Horacio Márquez-González, Solange G Koretzky","doi":"10.24875/BMHIM.23000143","DOIUrl":"https://doi.org/10.24875/BMHIM.23000143","url":null,"abstract":"<p><strong>Background: </strong>Hand hygiene (HH) is an important strategy for preventing health-care-associated infections (HAIs). Few programs focus on HH for family members and primary caregivers but fewer for patients. This study aimed to estimate the frequency with which hospitalized pediatric patients have hand contact with hospital surfaces.</p><p><strong>Methods: </strong>We conducted a cross-sectional descriptive observational study consisting of three phases: the first was the creation of an observation and data collection tool, the second was the training of the monitors, and the third was the observational study of hand contact and HH opportunities in hospitalized pediatric patients.</p><p><strong>Results: </strong>Over 3600 minutes of observation, 2032 HH opportunities were detected, averaging 33.8/h (SD 4.7) as determined by hand contact with hospital surfaces of hospitalized pediatric patients. In our study, infants and preschool children had the highest frequency of hand contact.</p><p><strong>Conclusion: </strong>The high frequency of hand contact of hospital surfaces by children suggests that hourly hand disinfection of patients and caregivers, objects and surfaces around the patients may be prevention measures that could be incorporated to reduce HAIs in pediatric hospitals.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 1","pages":"44-52"},"PeriodicalIF":0.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140179378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Norma A Balderrábano-Saucedo, Ana C Cepeda-Nieto, Luis D Ramírez-Calvillo, Ana C Berni-Betancourt, Silvia S Gómez-Delgadillo, Lorena D Cruz-Villar, Victor de J Suárez-Valencia
This review explores gender disparities in cardiac electrophysiology, highlighting differences in the electrical activity of the heart between men and women. It emphasizes the importance of understanding these variances for correct diagnosis and effective treatment of cardiac arrhythmias. Women show distinct cardiac characteristics influenced by sex hormones, affecting their susceptibility to various arrhythmias. The manuscript covers the classification, mechanisms, and management of arrhythmias in women, considering factors such as pregnancy and menopause. By addressing these gender-specific nuances, it aims to improve healthcare practices and outcomes for female patients with cardiac rhythm disorders.
{"title":"Unveiling the mystery of the female heart's rhythm: a look into gender inequalities in electrophysiology.","authors":"Norma A Balderrábano-Saucedo, Ana C Cepeda-Nieto, Luis D Ramírez-Calvillo, Ana C Berni-Betancourt, Silvia S Gómez-Delgadillo, Lorena D Cruz-Villar, Victor de J Suárez-Valencia","doi":"10.24875/BMHIM.24000030","DOIUrl":"https://doi.org/10.24875/BMHIM.24000030","url":null,"abstract":"<p><p>This review explores gender disparities in cardiac electrophysiology, highlighting differences in the electrical activity of the heart between men and women. It emphasizes the importance of understanding these variances for correct diagnosis and effective treatment of cardiac arrhythmias. Women show distinct cardiac characteristics influenced by sex hormones, affecting their susceptibility to various arrhythmias. The manuscript covers the classification, mechanisms, and management of arrhythmias in women, considering factors such as pregnancy and menopause. By addressing these gender-specific nuances, it aims to improve healthcare practices and outcomes for female patients with cardiac rhythm disorders.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 5","pages":"255-262"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}